| ORA price | $97.58 close on July 31, 2026, with pre-market near $96.92 on August 3, 2026 | StockAnalysis market data snapshot | August 3, 2026 |
| Market capitalization | $6.00 billion, verified as $97.58 x 61.45M shares with 0.06% variance | financial_rigor.py market cap verification and StockAnalysis | August 3, 2026 |
| Shares outstanding | 61.45 million shares, up 1.28% year over year, with institutions owning about 87.94% and insiders about 0.22% | StockAnalysis statistics | August 3, 2026 |
| Enterprise value | $8.75 billion, with 68.60x EV/earnings, 7.52x EV/sales, and 18.71x EV/EBITDA | StockAnalysis statistics | August 3, 2026 |
| TTM revenue | About $1.16 billion, up 31.5% year over year, cross-validated between StockAnalysis and Yahoo Finance within 0.00% | StockAnalysis and financial_rigor.py cross-validation | August 3, 2026 |
| TTM net income and EPS | About $127.6 million net income and $2.07 EPS, verified as 47.07x trailing PE at $97.58 | StockAnalysis statistics and financial_rigor.py | August 3, 2026 |
| Q1 2026 results | Record revenue of $403.9 million, up 75.8% year over year, with adjusted diluted EPS of $1.30 versus $0.90 consensus, and adjusted EBITDA of $194.9 million, up 29.7% | Ormat Q1 2026 earnings release and earnings call transcript | August 3, 2026 |
| FY2025 annual revenue and net income | $989.54 million revenue, up 12.49%, and $123.90 million net income, up 0.13% | StockAnalysis financials | August 3, 2026 |
| Cash, debt, and net debt | $654.65 million cash and equivalents, about $3.41 billion total debt, and net debt of roughly $2.6 billion or about 4.2x EBITDA as of March 31, 2026 | StockAnalysis balance sheet and Ormat Q1 2026 earnings call | August 3, 2026 |
| Financial leverage ratios | Debt/equity of 1.26, debt/EBITDA of 7.29x, interest coverage of 1.11x, and current ratio of 1.07 | StockAnalysis statistics | August 3, 2026 |
| TTM free cash flow | Negative $215.29 million, with operating cash flow of $325.67 million and capital expenditures of $540.96 million | StockAnalysis cash flow statement | August 3, 2026 |
| Valuation ratios | 47.07x trailing PE, 55.90x forward PE, 5.15x price/sales, 2.33x price/book, and 18.71x EV/EBITDA, verified with financial_rigor.py | StockAnalysis statistics and financial_rigor.py valuation verification | August 3, 2026 |
| Dividend | $0.48 annual, 0.49% yield, paid quarterly at $0.12 per share, with a 23.15% payout ratio and the last ex-dividend date on May 20, 2026 | StockAnalysis dividend history | August 3, 2026 |
| 2026 guidance | Revenue guidance of $1.11 to $1.16 billion (up 14.6% at the midpoint) and adjusted EBITDA guidance of $615 to $645 million, maintained after Q1 | Ormat Q1 2026 earnings call | August 3, 2026 |
| Analyst consensus | Buy from 13 analysts with an average price target of $133.83 and a range of $115 to $152 | StockAnalysis forecast | August 3, 2026 |
| Three-year scenario model | Bear $54.9, base $91.3, bull $130.9 using $2.07 EPS, 2% to 12% growth, and 25x to 45x terminal PE | financial_rigor.py three-scenario model | August 3, 2026 |
| Technical snapshot | 50-day moving average $120.46, 200-day moving average $115.72, RSI 33.11, beta 0.88, 52-week range $84.13 to $146.39, and 20-day average volume about 793,000 shares | StockAnalysis statistics | August 3, 2026 |
| Short interest | 5.18 million shares, about 8.43% of shares outstanding, with a short ratio of 5.55 days | StockAnalysis statistics | August 3, 2026 |